NephJC is a nephrology journal club that uses Twitter to discuss the research, guidelines, and editorials that drive nephrology.
This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.
This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.
Upcoming Twitter chats:
All scheduled chats are tentative. We may change the schedule depending on the whims of the NephJC work group.
April 23, 24 NephJC: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE)
April 30 #AskASN: navigating a physician-scientist career
May 14, 15 NephJC: Does Rate of Correction of HypERnatremia matter?
May 21 #AskASN: KidneyX
May 28, 29 NephJC: A new risk score for IgA Nephropathy
June #AskASN Kidney Health Initiative with new co-chair Dr. Ray Harris
June 11, 12 NephJC: Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial (SONAR)
July #AskASN Fellow Talk
August #AskASN: Why you must go to Kidney Week
September #AskASN: Renal Educator’s Community
The NephJC Twitter Journal Club Primer
The NephJC work group has produced a primer to document some of our thoughts on the practices on running a Twitter Journal Club. We think it is quite good. Take a look.
In the last year, NephJC has injected some statistical muscle into its editorial team (thank you Perry Wilson and Laurie Tomlinson). Then Manasi Bapat volunteered to create some cogent explainers for the various techniques that are routinely described in the methods section most of us skip over as we rush to the results. Here are the recent posts...
She’s back: A stats explainer of statistical modelling, goodness of fit and the Bayes information criterion from Manasi Bapat.
When a study is negative the work is not done. Time to separate a negative trial from an underpowered one. Learn how to think about this with Manasi Bapat.
Propensity scores…what’s up with that?
Multiple testing and the Bonferroni - NSMC intern and NephJC stats explainer Manasi Bapat breaks it down for you in this post.
Manasi deconstructs pragmatic trials for us. How are they different compared to efficacy & explanatory trials?
Manasi Bapat takes you behind the scenes to explain the need for doing sensitivity analyses
We begin a series of occasional commentary on the methods underlying the research being discussed. This edition: the 2 x 2 factorial designs.
The NephJC Book Club
is an annual tradition. Every summer we blog our way through a book of medical interest and have a Twitter-based book club discussion.
2018 Siddhartha Mukherjee's Laws of Medicine, Field Notes from an Uncertain Science
2017 Vanessa Grubb's, Hundreds of Interlaced Fingers.
2016 Eric Topol's, The Patient Will See You Now
2015 Atul Gawande's, Being Mortal
The winners of the third annual NephJC Kidneys
Thanks for voting. On Oct 26th at the #KidneyWk Beach Party we announced the winners in all 5 categories.
Rookie of the Year: Mohamed Elrggal
Most Engaged Scientist: Marvin Gonzalez
Study of the Year: A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops
Most Valuable Player: Maryam Khosravi
Nathan Hellman Social Media Project of the Year: The GlomCon Interactive Fellows’ Curriculum
See some great pictures from the event here.